Evidence map›Paper›PMID 27238384›Full record

ReviewDrug discovery today2016

Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine.

Tatsuyuki Yoshii, Yingying Geng, Shelly Peyton, Arthur M Mercurio, Vincent M Rotello

Abstract readReview
In one paragraph

Review in Drug discovery today, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2019
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatsuyuki YoshiiDepartment of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA.
Yingying GengMolecular and Cellular Biology Program, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA.
Shelly PeytonDepartment of Chemical Engineering, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA. Electronic address: speyton@ecs.umass.edu.
Arthur M MercurioDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: Arthur.Mercurio@umassmed.edu.
Vincent M RotelloDepartment of Chemistry, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA; Molecular and Cellular Biology Program, University of Massachusetts, 710 North Pleasant Street, Amherst, MA 01003, USA. Electronic address: rotello@chem.umass.edu.

Funding

CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
VEGF Signaling in Mammary TumorigenesisR01CA168464 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2012 to 2021
$3.7M
Recognition and Presentation of Alpha Helices using Nanoparticle ReceptorsR01GM077173 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ROTELLO, VINCENT M. · 2007 to 2018
$3.7M
Tissue-specific stem cells and breast cancer tissue tropism in bioengineered microenvironmentsDP2CA186573 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI PEYTON, SHELLY R. · 2013 to 2015
$2.6M
Integrin splicing and cancer stem cell fateR01CA203439 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2016 to 2020
$1.9M
NCI NIH HHS DP2 CA186573NCI NIH HHS R01 CA168464NCI NIH HHS R01 CA203439NIGMS NIH HHS R01 GM077173NIGMS NIH HHS T32 GM008515
6 · The paper itself

Abstract

Metastasis, drug resistance and recurrence in cancer are regulated by the tumor microenvironment. This review describes recent advances in understanding how cancer cells respond to extracellular environmental cues via integrins, how to build engineered microenvironments to study these interactions in vitro and how nanomaterials can be used to detect and target tumor microenvironments.

Indexed as

Biomechanical PhenomenaHumansIntegrinsNanomedicineNanostructuresNeoplasmsTumor MicroenvironmentIntegrins

Identifiers

PMID27238384
PMCPMC5035580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.